---
title: "14:10 ETAardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297220210.md"
description: "The Law Offices of Frank R. Cruz announces that investors with losses in Aardvark Therapeutics, Inc. (AARD) can lead a securities fraud class action lawsuit. The complaint alleges defendants made false statements and failed to disclose adverse facts about ARD-101's safety and prospects between February 2025 and May 2026. Investors must act before the October 13, 2026 deadline to participate."
datetime: "2026-08-27T18:11:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297220210.md)
  - [en](https://longbridge.com/en/news/297220210.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297220210.md)
generator: "portal-rs"
---

# 14:10 ETAardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

, /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Aardvark Therapeutics, Inc. (AARD) have opportunity to lead the securities fraud class action lawsuit.

**IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AARDVARK THERAPEUTICS, INC. (AARD), CLICK** **HERE** **BEFORE OCTOBER 13, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.**

**What Is The Lawsuit About?**  
The complaint filed in this class action alleges that between February 10, 2025 and May 14, 2026, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (i) ARD-101 was less safe than Defendants had led investors to believe; (ii) accordingly, ARD-101's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.  

**Contact Us To Participate or Learn More:**  
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.  
The Law Offices of Frank R. Cruz,  
Email us at: \[email protected\]  
Call us at: 310-914-5007  
Visit our website at: www.frankcruzlaw.com  
Follow us for updates on Twitter: twitter.com/FRC\_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. 

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. 

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE The Law Offices of Frank R. Cruz, Los Angeles

### Related Stocks

- [AARD.US](https://longbridge.com/en/quote/AARD.US.md)

## Related News & Research

- [11:22 ETShareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately](https://longbridge.com/en/news/297805881.md)
- [09:03 ETShareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately](https://longbridge.com/en/news/297521717.md)
- [14:30 ETPentair plc (PNR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/298066460.md)
- [12:35 ETHDFC Bank Limited (HDB) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/297812225.md)
- [16:59 ETHDB Investors Have Opportunity to Lead HDFC Bank Limited Securities Fraud Lawsuit](https://longbridge.com/en/news/298075647.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**